Drug Chatter -- Tracking biopharma stock chatter

Profile for Five Prime Therapeutics, Inc. (FPRX)

« Back to company index

FPRX Chatter Timeline

Stock Ticker for FPRX

Most Active Tweeters for FPRX

UserTweets
@OlympiaReport 6
@registrarjourn 6
@ZolmaxNews 6
@ThisLincolnian 6
@WatchlistN 6

Recent Tweets for FPRX

OlympiaReport @OlympiaReport
Analysts’ Recent Ratings Updates for Five Prime Therapeutics $FPRX https://t.co/h4uGT3yyu9
May 23rd 2018, 9:05am
ledgerzette @ledgerzette
Analysts’ Recent Ratings Updates for Five Prime Therapeutics $FPRX https://t.co/DSlYmdLcgf
May 23rd 2018, 6:05am
ZolmaxNews @ZolmaxNews
Five Prime Therapeutics $FPRX Upgraded to Buy by BidaskClub https://t.co/mAgpZLF0VN
May 23rd 2018, 1:05am
SolarMelt @SolarMelt
$FPRX Up in a bad market. Got a few presentations/abstracts/posters coming up at ASCO in two-to-three weeks. https://t.co/x7SmwjYZF5
May 22nd 2018, 8:05pm
gsi_momo_alerts @gsi_momo_alerts
Momentum Mover Alert: $FPRX https://t.co/xgj7zTIZTr
May 22nd 2018, 3:05pm
SolarMelt @SolarMelt
$FPRX Got a little Giddyup today too. https://t.co/p8x8gxiGNU
May 22nd 2018, 2:05pm
WeekHerald @WeekHerald
Five Prime Therapeutics $FPRX Raised to Buy at Zacks Investment Research https://t.co/zEqt3CtNPQ
May 22nd 2018, 7:05am
registrarjourn @registrarjourn
Five Prime Therapeutics $FPRX Raised to Buy at BidaskClub https://t.co/SuKb73jYYP
May 22nd 2018, 6:05am
ZolmaxNews @ZolmaxNews
Five Prime Therapeutics $FPRX Raised to Buy at Zacks Investment Research https://t.co/SSklse8qT1
May 22nd 2018, 2:05am
WatchlistN @WatchlistN
Five Prime Therapeutics $FPRX Raised to Buy at BidaskClub https://t.co/iypGYo44DD
May 22nd 2018, 2:05am
dakotafinancial @dakotafinancial
Five Prime Therapeutics $FPRX Raised to Buy at BidaskClub https://t.co/MwMIatQk7B
May 22nd 2018, 2:05am
Cdanno @Cdanno
RT @FivePrime_FPRX: We at $FPRX are creating the insights that drive #ClinicalScience and #DrugDiscovery. https://t.co/nBrHNUbATj
May 21st 2018, 8:05pm
FivePrime_FPRX @FivePrime_FPRX
We at $FPRX are creating the insights that drive #ClinicalScience and #DrugDiscovery. https://t.co/nBrHNUbATj
May 21st 2018, 12:05pm
WatchlistN @WatchlistN
Five Prime Therapeutics $FPRX Stock Rating Lowered by Zacks Investment Research https://t.co/NJmdxZD6a6
May 21st 2018, 8:05am
ThisLincolnian @ThisLincolnian
Five Prime Therapeutics $FPRX Lifted to Buy at Zacks Investment Research https://t.co/AnYRaaGgfK
May 21st 2018, 8:05am
WeekHerald @WeekHerald
Five Prime Therapeutics $FPRX Stock Rating Lowered by Zacks Investment Research https://t.co/TcqiSZA5M1
May 21st 2018, 7:05am
ledgerzette @ledgerzette
BidaskClub Upgrades Five Prime Therapeutics $FPRX to “Buy” https://t.co/79NlTFfYUA
May 21st 2018, 6:05am
ZolmaxNews @ZolmaxNews
Five Prime Therapeutics $FPRX Receives New Coverage from Analysts at Wedbush https://t.co/j57Yij9msa
May 21st 2018, 5:05am
dispatchtribune @dispatchtribune
Five Prime Therapeutics $FPRX Lifted to Buy at Zacks Investment Research https://t.co/u6uwnb2D5R
May 21st 2018, 5:05am
OlympiaReport @OlympiaReport
Five Prime Therapeutics $FPRX Stock Rating Upgraded by Zacks Investment Research https://t.co/fJtfClIHQz
May 21st 2018, 5:05am
OlympiaReport @OlympiaReport
BidaskClub Upgrades Five Prime Therapeutics $FPRX to “Buy” https://t.co/RIQNXNxRi1
May 21st 2018, 2:05am
TranscriptDaily @TranscriptDaily
Five Prime Therapeutics Inc $FPRX Receives Average Rating of “Buy” from Brokerages https://t.co/3WWFHAYXPX
May 20th 2018, 11:05pm
registrarjourn @registrarjourn
Analysts Set Five Prime Therapeutics Inc $FPRX Price Target at $37.67 https://t.co/VTGdNHHCyW
May 20th 2018, 11:05pm
OlympiaReport @OlympiaReport
Zacks Investment Research Lowers Five Prime Therapeutics $FPRX to Hold https://t.co/ZouooqyPZF
May 20th 2018, 11:05am
WeekHerald @WeekHerald
Five Prime Therapeutics $FPRX Upgraded to Buy at BidaskClub https://t.co/HP74Bhx2LJ
May 20th 2018, 9:05am
TheMarketsDaily @TheMarketsDaily
Five Prime Therapeutics $FPRX Upgraded to Buy at BidaskClub https://t.co/XPYp220rSU
May 20th 2018, 9:05am
WatchlistN @WatchlistN
Five Prime Therapeutics $FPRX Earns Neutral Rating from Analysts at Wedbush https://t.co/hNfj9X6iQ9
May 20th 2018, 9:05am
surveyist @surveyist
RT @SolarMelt: $FPRX FivePrime Very Active At ASCO - JUN 2018 Presentation/Abstracts/Posters - P1/2 - Cabiralizumab (PVNS) - P2 - Cabiraliz…
May 19th 2018, 6:05pm
SolarMelt @SolarMelt
$FPRX Looks even better on a weekly chart. I've got six buy signals here, including a Double Bottom and Parabolic S… https://t.co/544T2fT8LT
May 19th 2018, 3:05pm
SolarMelt @SolarMelt
$FPRX The chart looks pretty good too. https://t.co/3QywA1tHxb
May 19th 2018, 2:05pm
SolarMelt @SolarMelt
$FPRX FivePrime Very Active At ASCO - JUN 2018 Presentation/Abstracts/Posters - P1/2 - Cabiralizumab (PVNS) - P2 -… https://t.co/CVAfvFCblx
May 19th 2018, 2:05pm
TickerReport @TickerReport
Five Prime Therapeutics $FPRX Stock Rating Upgraded by Zacks Investment Research https://t.co/ACYyDxhmAw
May 19th 2018, 1:05pm
ConsumerFeed @ConsumerFeed
Five Prime Therapeutics $FPRX Upgraded to “Buy” by Zacks Investment Research https://t.co/07cjJE5lP8
May 19th 2018, 1:05pm
AmericanBanking @AmericanBanking
Five Prime Therapeutics $FPRX Upgraded to “Buy” by BidaskClub https://t.co/wsgX261h4L #stocks
May 19th 2018, 1:05pm
dailypoliticaln @dailypoliticaln
Five Prime Therapeutics $FPRX Now Covered by Wedbush https://t.co/skRbQkJgwd
May 19th 2018, 11:05am
TickerReport @TickerReport
Five Prime Therapeutics $FPRX Now Covered by Wedbush https://t.co/LiPtjvaUFg
May 19th 2018, 11:05am
registrarjourn @registrarjourn
Five Prime Therapeutics $FPRX Upgraded to “Buy” by Zacks Investment Research https://t.co/GX2uj3mebN
May 19th 2018, 11:05am
ConsumerFeed @ConsumerFeed
Five Prime Therapeutics $FPRX Downgraded by Zacks Investment Research to “Hold” https://t.co/BkqTpH6j1l
May 19th 2018, 5:05am
dailypoliticaln @dailypoliticaln
Five Prime Therapeutics $FPRX Raised to Buy at BidaskClub https://t.co/HOpEu86AuX
May 19th 2018, 4:05am
TickerReport @TickerReport
Five Prime Therapeutics $FPRX Raised to Buy at BidaskClub https://t.co/pya1wiMYgD
May 19th 2018, 4:05am
AmericanBanking @AmericanBanking
Five Prime Therapeutics $FPRX Stock Rating Upgraded by Zacks Investment Research https://t.co/0mSvlwOGNq #stocks
May 18th 2018, 10:05pm
WatchlistN @WatchlistN
Five Prime Therapeutics $FPRX Rating Increased to Buy at Zacks Investment Research https://t.co/JMfVimC5Y7
May 18th 2018, 10:05pm
ZolmaxNews @ZolmaxNews
Five Prime Therapeutics $FPRX Downgraded by Zacks Investment Research https://t.co/h9TRU5dmep
May 18th 2018, 1:05pm
dailypoliticaln @dailypoliticaln
Five Prime Therapeutics $FPRX Downgraded to Hold at Zacks Investment Research https://t.co/x7HwaEKBwk
May 18th 2018, 1:05pm
ConsumerFeed @ConsumerFeed
Five Prime Therapeutics $FPRX Coverage Initiated by Analysts at Wedbush https://t.co/KFZXaMGjTu
May 18th 2018, 1:05pm
ThisLincolnian @ThisLincolnian
Five Prime Therapeutics $FPRX Coverage Initiated by Analysts at Wedbush https://t.co/UYgAlc3lCD
May 18th 2018, 1:05pm
stocknewsdotcom @stocknewsdotcom
$FPRX Wedbush initiates as a Neutral https://t.co/1YbHlPsiAI
May 18th 2018, 8:05am
tradnews_ @tradnews_
RT @AlertTrade: UP/DOWNGRADES ? $FPRX: Wedbush starts at Neutral https://t.co/Xcl5xoxFds via ? https://t.co/VS8RO1bzXJ
May 18th 2018, 8:05am
AlertTrade @AlertTrade
UP/DOWNGRADES ? $FPRX: Wedbush starts at Neutral https://t.co/Xcl5xoxFds via ? https://t.co/VS8RO1bzXJ
May 18th 2018, 8:05am
WarrenofWallSt @WarrenofWallSt
Traditional fundamentals don't apply to Biotechs like #FivePrimeTherapeutics $FPRX https://t.co/ngo1kcFMVt https://t.co/4Zy15t7Sfi
May 18th 2018, 1:05am

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.